- Home
- EXEL vs NDSN Comparison
EXEL vs NDSN Comparison
Compare EXEL & NDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- NDSN
- Stock Information
- Founded
- EXEL 1994
- NDSN 1935
- Country
- EXEL United States
- NDSN United States
- Employees
- EXEL N/A
- NDSN N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- NDSN Industrial Machinery/Components
- Sector
- EXEL Health Care
- NDSN Industrials
- Exchange
- EXEL Nasdaq
- NDSN Nasdaq
- Market Cap
- EXEL 10.4B
- NDSN 10.1B
- IPO Year
- EXEL 2000
- NDSN N/A
- Fundamental
- Price
- EXEL $37.88
- NDSN $225.03
- Analyst Decision
- EXEL Buy
- NDSN Strong Buy
- Analyst Count
- EXEL 21
- NDSN 6
- Target Price
- EXEL $43.65
- NDSN $265.33
- AVG Volume (30 Days)
- EXEL 2.4M
- NDSN 375.6K
- Earning Date
- EXEL 10-28-2025
- NDSN 08-20-2025
- Dividend Yield
- EXEL N/A
- NDSN 1.39%
- EPS Growth
- EXEL 81.76
- NDSN N/A
- EPS
- EXEL 2.08
- NDSN 7.95
- Revenue
- EXEL $2,230,005,000.00
- NDSN $2,784,349,000.00
- Revenue This Year
- EXEL $9.24
- NDSN $5.77
- Revenue Next Year
- EXEL $13.04
- NDSN $4.99
- P/E Ratio
- EXEL $18.24
- NDSN $28.30
- Revenue Growth
- EXEL 10.73
- NDSN 4.49
- 52 Week Low
- EXEL $25.12
- NDSN $165.03
- 52 Week High
- EXEL $49.62
- NDSN $266.86
- Technical
- Relative Strength Index (RSI)
- EXEL 44.99
- NDSN 57.33
- Support Level
- EXEL $36.23
- NDSN $220.35
- Resistance Level
- EXEL $38.95
- NDSN $228.79
- Average True Range (ATR)
- EXEL 0.85
- NDSN 5.02
- MACD
- EXEL 0.13
- NDSN 0.36
- Stochastic Oscillator
- EXEL 60.66
- NDSN 55.89
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About NDSN Nordson Corporation
Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.7 billion in revenue in its fiscal 2024.